The Broad Spectrum HDAC Inhibitor PCI-24781 Induces Caspase- and ROS-Dependent Apoptosis and is Synergistic with Bortezomib in Lymphoma [PDF]
We investigated the cytotoxicity and biology of the novel broad-spectrum hydroxamic acid-based histone deacetylase inhibitor (HDACi), PCI-24781. PCI-24781 was studied alone and combined with bortezomib in Hodgkin lymphoma (L428) and non-Hodgkin's ...
Andrew Evens +9 more
core +1 more source
Effect of Yuzu (Citrus junos) Seed Limonoids and Spermine on Intestinal Microbiota and Hypothalamic Tissue in the Sandhoff Disease Mouse Model. [PDF]
Minamisawa M +7 more
europepmc +1 more source
Therapeutic benefit after intracranial gene therapy delivered during the symptomatic stage in a feline model of Sandhoff disease. [PDF]
McCurdy VJ +10 more
europepmc +1 more source
Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunction.
Glycosphingolipids (GSL) are important bioactive membrane components. GSLs containing sialic acids, known as gangliosides, are highly abundant in the brain and diseases of ganglioside metabolism cause severe early-onset neurodegeneration. The ganglioside
Alex S Nicholson +11 more
doaj +1 more source
Abnormal epiphyseal development in a feline model of Sandhoff disease. [PDF]
McNulty MA +9 more
europepmc +1 more source
Beneficial Effects of Acetyl-DL-Leucine (ADLL) in a Mouse Model of Sandhoff Disease. [PDF]
Kaya E +5 more
europepmc +1 more source
Brain endothelial specific gene therapy improves experimental Sandhoff disease. [PDF]
Dogbevia G +4 more
europepmc +1 more source
Simplifying complexity: genetically resculpting glycosphingolipid synthesis pathways in mice to reveal function [PDF]
core +1 more source
A feasibility study of mHealth and wearable technology in late onset GM2 gangliosidosis (Tay-Sachs and Sandhoff Disease). [PDF]
Davies EH, Johnston J, Toro C, Tifft CJ.
europepmc +1 more source
Bioprinting neural tissue to decode Sandhoff disease: promise and barriers. [PDF]
Ullah SH +4 more
europepmc +1 more source

